カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の2型糖尿病用注射剤市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Injectable Drugs For Type-2 Diabete Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19426）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19426
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：97
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の2型糖尿病用注射剤市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

2型糖尿病用注射剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の2型糖尿病用注射剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

2型糖尿病用注射剤市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・インスリン、エキセナチド、リラグルチド、プラムリンチド、その他

用途別セグメントは次のように区分されます。
・病院薬局、店舗薬局、オンライン薬局、その他

世界の2型糖尿病用注射剤市場の主要な市場プレーヤーは以下のとおりです。
・AstraZeneca、GSK、Merck、Boehringer Ingelheim、Novo Nordisk、Sanofi、Eli Lilly

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、2型糖尿病用注射剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な2型糖尿病用注射剤メーカーの企業概要、2019年～2022年までの2型糖尿病用注射剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な2型糖尿病用注射剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別2型糖尿病用注射剤の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの2型糖尿病用注射剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での2型糖尿病用注射剤市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および2型糖尿病用注射剤の産業チェーンを掲載しています。
・第13、14、15章では、2型糖尿病用注射剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 2型糖尿病用注射剤の概要
- 種類別分析（2017年vs2021年vs2028年）：インスリン、エキセナチド、リラグルチド、プラムリンチド、その他
- 用途別分析（2017年vs2021年vs2028年）：病院薬局、店舗薬局、オンライン薬局、その他
- 世界の2型糖尿病用注射剤市場規模・予測
- 世界の2型糖尿病用注射剤生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- AstraZeneca、GSK、Merck、Boehringer Ingelheim、Novo Nordisk、Sanofi、Eli Lilly
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：インスリン、エキセナチド、リラグルチド、プラムリンチド、その他
・用途別分析2017年-2028年：病院薬局、店舗薬局、オンライン薬局、その他
・2型糖尿病用注射剤の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・2型糖尿病用注射剤のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・2型糖尿病用注射剤のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・2型糖尿病用注射剤の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・2型糖尿病用注射剤の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Injectable Drugs For Type-2 Diabete market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Injectable Drugs For Type-2 Diabete market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacy accounting for % of the Injectable Drugs For Type-2 Diabete global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Insulin segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Injectable Drugs For Type-2 Diabete include AstraZeneca, GSK, Merck, Boehringer Ingelheim, and Novo Nordisk, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Injectable Drugs For Type-2 Diabete market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Insulin
Exenatide
Liragultide
Pramlintide
Others
Market segment by Application can be divided into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
The key market players for global Injectable Drugs For Type-2 Diabete market are listed below:
AstraZeneca
GSK
Merck
Boehringer Ingelheim
Novo Nordisk
Sanofi
Eli Lilly
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Injectable Drugs For Type-2 Diabete product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Injectable Drugs For Type-2 Diabete, with price, sales, revenue and global market share of Injectable Drugs For Type-2 Diabete from 2019 to 2022.
Chapter 3, the Injectable Drugs For Type-2 Diabete competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Injectable Drugs For Type-2 Diabete breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Injectable Drugs For Type-2 Diabete market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Injectable Drugs For Type-2 Diabete.
Chapter 13, 14, and 15, to describe Injectable Drugs For Type-2 Diabete sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Injectable Drugs For Type-2 Diabete Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Injectable Drugs For Type-2 Diabete Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Insulin
1.2.3 Exenatide
1.2.4 Liragultide
1.2.5 Pramlintide
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Injectable Drugs For Type-2 Diabete Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Global Injectable Drugs For Type-2 Diabete Market Size & Forecast
1.4.1 Global Injectable Drugs For Type-2 Diabete Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Injectable Drugs For Type-2 Diabete Sales in Volume (2017-2028)
1.4.3 Global Injectable Drugs For Type-2 Diabete Price (2017-2028)
1.5 Global Injectable Drugs For Type-2 Diabete Production Capacity Analysis
1.5.1 Global Injectable Drugs For Type-2 Diabete Total Production Capacity (2017-2028)
1.5.2 Global Injectable Drugs For Type-2 Diabete Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Injectable Drugs For Type-2 Diabete Market Drivers
1.6.2 Injectable Drugs For Type-2 Diabete Market Restraints
1.6.3 Injectable Drugs For Type-2 Diabete Trends Analysis
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Injectable Drugs For Type-2 Diabete Product and Services
2.1.4 AstraZeneca Injectable Drugs For Type-2 Diabete Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Injectable Drugs For Type-2 Diabete Product and Services
2.2.4 GSK Injectable Drugs For Type-2 Diabete Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Injectable Drugs For Type-2 Diabete Product and Services
2.3.4 Merck Injectable Drugs For Type-2 Diabete Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Boehringer Ingelheim
2.4.1 Boehringer Ingelheim Details
2.4.2 Boehringer Ingelheim Major Business
2.4.3 Boehringer Ingelheim Injectable Drugs For Type-2 Diabete Product and Services
2.4.4 Boehringer Ingelheim Injectable Drugs For Type-2 Diabete Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Novo Nordisk
2.5.1 Novo Nordisk Details
2.5.2 Novo Nordisk Major Business
2.5.3 Novo Nordisk Injectable Drugs For Type-2 Diabete Product and Services
2.5.4 Novo Nordisk Injectable Drugs For Type-2 Diabete Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi Injectable Drugs For Type-2 Diabete Product and Services
2.6.4 Sanofi Injectable Drugs For Type-2 Diabete Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Eli Lilly
2.7.1 Eli Lilly Details
2.7.2 Eli Lilly Major Business
2.7.3 Eli Lilly Injectable Drugs For Type-2 Diabete Product and Services
2.7.4 Eli Lilly Injectable Drugs For Type-2 Diabete Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Injectable Drugs For Type-2 Diabete Breakdown Data by Manufacturer
3.1 Global Injectable Drugs For Type-2 Diabete Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Injectable Drugs For Type-2 Diabete Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Injectable Drugs For Type-2 Diabete
3.4 Market Concentration Rate
3.4.1 Top 3 Injectable Drugs For Type-2 Diabete Manufacturer Market Share in 2021
3.4.2 Top 6 Injectable Drugs For Type-2 Diabete Manufacturer Market Share in 2021
3.5 Global Injectable Drugs For Type-2 Diabete Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Injectable Drugs For Type-2 Diabete Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Injectable Drugs For Type-2 Diabete Market Size by Region
4.1.1 Global Injectable Drugs For Type-2 Diabete Sales in Volume by Region (2017-2028)
4.1.2 Global Injectable Drugs For Type-2 Diabete Revenue by Region (2017-2028)
4.2 North America Injectable Drugs For Type-2 Diabete Revenue (2017-2028)
4.3 Europe Injectable Drugs For Type-2 Diabete Revenue (2017-2028)
4.4 Asia-Pacific Injectable Drugs For Type-2 Diabete Revenue (2017-2028)
4.5 South America Injectable Drugs For Type-2 Diabete Revenue (2017-2028)
4.6 Middle East and Africa Injectable Drugs For Type-2 Diabete Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Injectable Drugs For Type-2 Diabete Sales in Volume by Type (2017-2028)
5.2 Global Injectable Drugs For Type-2 Diabete Revenue by Type (2017-2028)
5.3 Global Injectable Drugs For Type-2 Diabete Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Injectable Drugs For Type-2 Diabete Sales in Volume by Application (2017-2028)
6.2 Global Injectable Drugs For Type-2 Diabete Revenue by Application (2017-2028)
6.3 Global Injectable Drugs For Type-2 Diabete Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Injectable Drugs For Type-2 Diabete Sales by Type (2017-2028)
7.2 North America Injectable Drugs For Type-2 Diabete Sales by Application (2017-2028)
7.3 North America Injectable Drugs For Type-2 Diabete Market Size by Country
7.3.1 North America Injectable Drugs For Type-2 Diabete Sales in Volume by Country (2017-2028)
7.3.2 North America Injectable Drugs For Type-2 Diabete Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Injectable Drugs For Type-2 Diabete Sales by Type (2017-2028)
8.2 Europe Injectable Drugs For Type-2 Diabete Sales by Application (2017-2028)
8.3 Europe Injectable Drugs For Type-2 Diabete Market Size by Country
8.3.1 Europe Injectable Drugs For Type-2 Diabete Sales in Volume by Country (2017-2028)
8.3.2 Europe Injectable Drugs For Type-2 Diabete Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Injectable Drugs For Type-2 Diabete Sales by Type (2017-2028)
9.2 Asia-Pacific Injectable Drugs For Type-2 Diabete Sales by Application (2017-2028)
9.3 Asia-Pacific Injectable Drugs For Type-2 Diabete Market Size by Region
9.3.1 Asia-Pacific Injectable Drugs For Type-2 Diabete Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Injectable Drugs For Type-2 Diabete Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Injectable Drugs For Type-2 Diabete Sales by Type (2017-2028)
10.2 South America Injectable Drugs For Type-2 Diabete Sales by Application (2017-2028)
10.3 South America Injectable Drugs For Type-2 Diabete Market Size by Country
10.3.1 South America Injectable Drugs For Type-2 Diabete Sales in Volume by Country (2017-2028)
10.3.2 South America Injectable Drugs For Type-2 Diabete Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Injectable Drugs For Type-2 Diabete Sales by Type (2017-2028)
11.2 Middle East & Africa Injectable Drugs For Type-2 Diabete Sales by Application (2017-2028)
11.3 Middle East & Africa Injectable Drugs For Type-2 Diabete Market Size by Country
11.3.1 Middle East & Africa Injectable Drugs For Type-2 Diabete Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Injectable Drugs For Type-2 Diabete Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Injectable Drugs For Type-2 Diabete and Key Manufacturers
12.2 Manufacturing Costs Percentage of Injectable Drugs For Type-2 Diabete
12.3 Injectable Drugs For Type-2 Diabete Production Process
12.4 Injectable Drugs For Type-2 Diabete Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Injectable Drugs For Type-2 Diabete Typical Distributors
13.3 Injectable Drugs For Type-2 Diabete Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Injectable Drugs For Type-2 Diabete Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Injectable Drugs For Type-2 Diabete Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Injectable Drugs For Type-2 Diabete Product and Services
Table 6. AstraZeneca Injectable Drugs For Type-2 Diabete Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK Injectable Drugs For Type-2 Diabete Product and Services
Table 10. GSK Injectable Drugs For Type-2 Diabete Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck Injectable Drugs For Type-2 Diabete Product and Services
Table 14. Merck Injectable Drugs For Type-2 Diabete Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 16. Boehringer Ingelheim Major Business
Table 17. Boehringer Ingelheim Injectable Drugs For Type-2 Diabete Product and Services
Table 18. Boehringer Ingelheim Injectable Drugs For Type-2 Diabete Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 20. Novo Nordisk Major Business
Table 21. Novo Nordisk Injectable Drugs For Type-2 Diabete Product and Services
Table 22. Novo Nordisk Injectable Drugs For Type-2 Diabete Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Sanofi Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Major Business
Table 25. Sanofi Injectable Drugs For Type-2 Diabete Product and Services
Table 26. Sanofi Injectable Drugs For Type-2 Diabete Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 28. Eli Lilly Major Business
Table 29. Eli Lilly Injectable Drugs For Type-2 Diabete Product and Services
Table 30. Eli Lilly Injectable Drugs For Type-2 Diabete Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Injectable Drugs For Type-2 Diabete Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 32. Global Injectable Drugs For Type-2 Diabete Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in Injectable Drugs For Type-2 Diabete, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global Injectable Drugs For Type-2 Diabete Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Injectable Drugs For Type-2 Diabete Production Site of Key Manufacturer
Table 36. Injectable Drugs For Type-2 Diabete New Entrant and Capacity Expansion Plans
Table 37. Injectable Drugs For Type-2 Diabete Mergers & Acquisitions in the Past Five Years
Table 38. Global Injectable Drugs For Type-2 Diabete Sales by Region (2017-2022) & (K Units)
Table 39. Global Injectable Drugs For Type-2 Diabete Sales by Region (2023-2028) & (K Units)
Table 40. Global Injectable Drugs For Type-2 Diabete Revenue by Region (2017-2022) & (USD Million)
Table 41. Global Injectable Drugs For Type-2 Diabete Revenue by Region (2023-2028) & (USD Million)
Table 42. Global Injectable Drugs For Type-2 Diabete Sales by Type (2017-2022) & (K Units)
Table 43. Global Injectable Drugs For Type-2 Diabete Sales by Type (2023-2028) & (K Units)
Table 44. Global Injectable Drugs For Type-2 Diabete Revenue by Type (2017-2022) & (USD Million)
Table 45. Global Injectable Drugs For Type-2 Diabete Revenue by Type (2023-2028) & (USD Million)
Table 46. Global Injectable Drugs For Type-2 Diabete Price by Type (2017-2022) & (US$/Unit)
Table 47. Global Injectable Drugs For Type-2 Diabete Price by Type (2023-2028) & (US$/Unit)
Table 48. Global Injectable Drugs For Type-2 Diabete Sales by Application (2017-2022) & (K Units)
Table 49. Global Injectable Drugs For Type-2 Diabete Sales by Application (2023-2028) & (K Units)
Table 50. Global Injectable Drugs For Type-2 Diabete Revenue by Application (2017-2022) & (USD Million)
Table 51. Global Injectable Drugs For Type-2 Diabete Revenue by Application (2023-2028) & (USD Million)
Table 52. Global Injectable Drugs For Type-2 Diabete Price by Application (2017-2022) & (US$/Unit)
Table 53. Global Injectable Drugs For Type-2 Diabete Price by Application (2023-2028) & (US$/Unit)
Table 54. North America Injectable Drugs For Type-2 Diabete Sales by Country (2017-2022) & (K Units)
Table 55. North America Injectable Drugs For Type-2 Diabete Sales by Country (2023-2028) & (K Units)
Table 56. North America Injectable Drugs For Type-2 Diabete Revenue by Country (2017-2022) & (USD Million)
Table 57. North America Injectable Drugs For Type-2 Diabete Revenue by Country (2023-2028) & (USD Million)
Table 58. North America Injectable Drugs For Type-2 Diabete Sales by Type (2017-2022) & (K Units)
Table 59. North America Injectable Drugs For Type-2 Diabete Sales by Type (2023-2028) & (K Units)
Table 60. North America Injectable Drugs For Type-2 Diabete Sales by Application (2017-2022) & (K Units)
Table 61. North America Injectable Drugs For Type-2 Diabete Sales by Application (2023-2028) & (K Units)
Table 62. Europe Injectable Drugs For Type-2 Diabete Sales by Country (2017-2022) & (K Units)
Table 63. Europe Injectable Drugs For Type-2 Diabete Sales by Country (2023-2028) & (K Units)
Table 64. Europe Injectable Drugs For Type-2 Diabete Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe Injectable Drugs For Type-2 Diabete Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe Injectable Drugs For Type-2 Diabete Sales by Type (2017-2022) & (K Units)
Table 67. Europe Injectable Drugs For Type-2 Diabete Sales by Type (2023-2028) & (K Units)
Table 68. Europe Injectable Drugs For Type-2 Diabete Sales by Application (2017-2022) & (K Units)
Table 69. Europe Injectable Drugs For Type-2 Diabete Sales by Application (2023-2028) & (K Units)
Table 70. Asia-Pacific Injectable Drugs For Type-2 Diabete Sales by Region (2017-2022) & (K Units)
Table 71. Asia-Pacific Injectable Drugs For Type-2 Diabete Sales by Region (2023-2028) & (K Units)
Table 72. Asia-Pacific Injectable Drugs For Type-2 Diabete Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific Injectable Drugs For Type-2 Diabete Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific Injectable Drugs For Type-2 Diabete Sales by Type (2017-2022) & (K Units)
Table 75. Asia-Pacific Injectable Drugs For Type-2 Diabete Sales by Type (2023-2028) & (K Units)
Table 76. Asia-Pacific Injectable Drugs For Type-2 Diabete Sales by Application (2017-2022) & (K Units)
Table 77. Asia-Pacific Injectable Drugs For Type-2 Diabete Sales by Application (2023-2028) & (K Units)
Table 78. South America Injectable Drugs For Type-2 Diabete Sales by Country (2017-2022) & (K Units)
Table 79. South America Injectable Drugs For Type-2 Diabete Sales by Country (2023-2028) & (K Units)
Table 80. South America Injectable Drugs For Type-2 Diabete Revenue by Country (2017-2022) & (USD Million)
Table 81. South America Injectable Drugs For Type-2 Diabete Revenue by Country (2023-2028) & (USD Million)
Table 82. South America Injectable Drugs For Type-2 Diabete Sales by Type (2017-2022) & (K Units)
Table 83. South America Injectable Drugs For Type-2 Diabete Sales by Type (2023-2028) & (K Units)
Table 84. South America Injectable Drugs For Type-2 Diabete Sales by Application (2017-2022) & (K Units)
Table 85. South America Injectable Drugs For Type-2 Diabete Sales by Application (2023-2028) & (K Units)
Table 86. Middle East & Africa Injectable Drugs For Type-2 Diabete Sales by Region (2017-2022) & (K Units)
Table 87. Middle East & Africa Injectable Drugs For Type-2 Diabete Sales by Region (2023-2028) & (K Units)
Table 88. Middle East & Africa Injectable Drugs For Type-2 Diabete Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa Injectable Drugs For Type-2 Diabete Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa Injectable Drugs For Type-2 Diabete Sales by Type (2017-2022) & (K Units)
Table 91. Middle East & Africa Injectable Drugs For Type-2 Diabete Sales by Type (2023-2028) & (K Units)
Table 92. Middle East & Africa Injectable Drugs For Type-2 Diabete Sales by Application (2017-2022) & (K Units)
Table 93. Middle East & Africa Injectable Drugs For Type-2 Diabete Sales by Application (2023-2028) & (K Units)
Table 94. Injectable Drugs For Type-2 Diabete Raw Material
Table 95. Key Manufacturers of Injectable Drugs For Type-2 Diabete Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Injectable Drugs For Type-2 Diabete Typical Distributors
Table 99. Injectable Drugs For Type-2 Diabete Typical Customers
List of Figures
Figure 1. Injectable Drugs For Type-2 Diabete Picture
Figure 2. Global Injectable Drugs For Type-2 Diabete Revenue Market Share by Type in 2021
Figure 3. Insulin
Figure 4. Exenatide
Figure 5. Liragultide
Figure 6. Pramlintide
Figure 7. Others
Figure 8. Global Injectable Drugs For Type-2 Diabete Revenue Market Share by Application in 2021
Figure 9. Hospital Pharmacy
Figure 10. Retail Pharmacy
Figure 11. Online Pharmacy
Figure 12. Others
Figure 13. Global Injectable Drugs For Type-2 Diabete Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 14. Global Injectable Drugs For Type-2 Diabete Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Injectable Drugs For Type-2 Diabete Sales (2017-2028) & (K Units)
Figure 16. Global Injectable Drugs For Type-2 Diabete Price (2017-2028) & (US$/Unit)
Figure 17. Global Injectable Drugs For Type-2 Diabete Production Capacity (2017-2028) & (K Units)
Figure 18. Global Injectable Drugs For Type-2 Diabete Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Injectable Drugs For Type-2 Diabete Market Drivers
Figure 20. Injectable Drugs For Type-2 Diabete Market Restraints
Figure 21. Injectable Drugs For Type-2 Diabete Market Trends
Figure 22. Global Injectable Drugs For Type-2 Diabete Sales Market Share by Manufacturer in 2021
Figure 23. Global Injectable Drugs For Type-2 Diabete Revenue Market Share by Manufacturer in 2021
Figure 24. Injectable Drugs For Type-2 Diabete Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Injectable Drugs For Type-2 Diabete Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Injectable Drugs For Type-2 Diabete Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Injectable Drugs For Type-2 Diabete Sales Market Share by Region (2017-2028)
Figure 28. Global Injectable Drugs For Type-2 Diabete Revenue Market Share by Region (2017-2028)
Figure 29. North America Injectable Drugs For Type-2 Diabete Revenue (2017-2028) & (USD Million)
Figure 30. Europe Injectable Drugs For Type-2 Diabete Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Injectable Drugs For Type-2 Diabete Revenue (2017-2028) & (USD Million)
Figure 32. South America Injectable Drugs For Type-2 Diabete Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Injectable Drugs For Type-2 Diabete Revenue (2017-2028) & (USD Million)
Figure 34. Global Injectable Drugs For Type-2 Diabete Sales Market Share by Type (2017-2028)
Figure 35. Global Injectable Drugs For Type-2 Diabete Revenue Market Share by Type (2017-2028)
Figure 36. Global Injectable Drugs For Type-2 Diabete Price by Type (2017-2028) & (US$/Unit)
Figure 37. Global Injectable Drugs For Type-2 Diabete Sales Market Share by Application (2017-2028)
Figure 38. Global Injectable Drugs For Type-2 Diabete Revenue Market Share by Application (2017-2028)
Figure 39. Global Injectable Drugs For Type-2 Diabete Price by Application (2017-2028) & (US$/Unit)
Figure 40. North America Injectable Drugs For Type-2 Diabete Sales Market Share by Type (2017-2028)
Figure 41. North America Injectable Drugs For Type-2 Diabete Sales Market Share by Application (2017-2028)
Figure 42. North America Injectable Drugs For Type-2 Diabete Sales Market Share by Country (2017-2028)
Figure 43. North America Injectable Drugs For Type-2 Diabete Revenue Market Share by Country (2017-2028)
Figure 44. United States Injectable Drugs For Type-2 Diabete Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Injectable Drugs For Type-2 Diabete Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Injectable Drugs For Type-2 Diabete Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Injectable Drugs For Type-2 Diabete Sales Market Share by Type (2017-2028)
Figure 48. Europe Injectable Drugs For Type-2 Diabete Sales Market Share by Application (2017-2028)
Figure 49. Europe Injectable Drugs For Type-2 Diabete Sales Market Share by Country (2017-2028)
Figure 50. Europe Injectable Drugs For Type-2 Diabete Revenue Market Share by Country (2017-2028)
Figure 51. Germany Injectable Drugs For Type-2 Diabete Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Injectable Drugs For Type-2 Diabete Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Injectable Drugs For Type-2 Diabete Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Injectable Drugs For Type-2 Diabete Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Injectable Drugs For Type-2 Diabete Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Injectable Drugs For Type-2 Diabete Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Injectable Drugs For Type-2 Diabete Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Injectable Drugs For Type-2 Diabete Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Injectable Drugs For Type-2 Diabete Revenue Market Share by Region (2017-2028)
Figure 60. China Injectable Drugs For Type-2 Diabete Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Injectable Drugs For Type-2 Diabete Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Injectable Drugs For Type-2 Diabete Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Injectable Drugs For Type-2 Diabete Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Injectable Drugs For Type-2 Diabete Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Injectable Drugs For Type-2 Diabete Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Injectable Drugs For Type-2 Diabete Sales Market Share by Type (2017-2028)
Figure 67. South America Injectable Drugs For Type-2 Diabete Sales Market Share by Application (2017-2028)
Figure 68. South America Injectable Drugs For Type-2 Diabete Sales Market Share by Country (2017-2028)
Figure 69. South America Injectable Drugs For Type-2 Diabete Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Injectable Drugs For Type-2 Diabete Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Injectable Drugs For Type-2 Diabete Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Injectable Drugs For Type-2 Diabete Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa Injectable Drugs For Type-2 Diabete Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Injectable Drugs For Type-2 Diabete Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Injectable Drugs For Type-2 Diabete Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Injectable Drugs For Type-2 Diabete Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Injectable Drugs For Type-2 Diabete Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Injectable Drugs For Type-2 Diabete Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Injectable Drugs For Type-2 Diabete Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Injectable Drugs For Type-2 Diabete in 2021
Figure 81. Manufacturing Process Analysis of Injectable Drugs For Type-2 Diabete
Figure 82. Injectable Drugs For Type-2 Diabete Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の注射用糖尿病治療薬市場2022年：市場規模予測（～2028年）
  • 世界の腫瘍用ジェネリック注射剤市場2022年：市場規模予測（～2028年）
  • 世界の注射用発作治療薬市場2022年：市場規模予測（～2028年）
  • 世界のペプチド抗生物質無菌注射剤市場2022年：市場規模予測（～2028年）
  • 注射可能型発作治療薬の世界市場2023年：ホスフェニトイン、ミダゾラム、カルバマゼピン、セノバメート、ガバペンチン、フェニトイン、ラモトリジン、トピラメート、レベチラセタム、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19426 )"世界の2型糖尿病用注射剤市場2022年：市場規模予測（～2028年）" (英文：Global Injectable Drugs For Type-2 Diabete Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。